Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Monthly Archives: November 2022

MissionIRNewsBreaks – Eloro Resources Ltd. (TSX.V: ELO) (OTCQX: ELRRF) (FSE: P2QM) Uncovering Potential for Iska Iska to Become ‘Bonanza Style’ Bolivian Polymetallic Discovery

Posted on November 29, 2022 by MissionIR

Eloro Resources (TSX.V: ELO) (OTCQX: ELRRF) (FSE: P2QM) today announced assay results from eight additional diamond drill holes from its ongoing drilling program at the Iska Iska silver-tin polymetallic project in the Potosi Department, southern Bolivia. According to the update, … Continue reading →

Posted in Eloro Resources Ltd. ELRRF | Leave a comment

BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) Pipeline Focused on Creating Innovative Immunotherapeutic Products for Treating Underserved Infectious and Autoimmune Diseases

Posted on November 29, 2022 by MissionIR

BiondVax Pharmaceuticals (NASDAQ: BVXV) is a biotechnology company focused on developing, manufacturing, and commercializing innovative immunotherapeutic products primarily for the treatment of infectious diseases and autoimmune diseases – with a primary focus on diseases underserved by current treatments and with … Continue reading →

Posted in BiondVax Pharmaceuticals Ltd. BVXV | Leave a comment

EverGen Infrastructure Corp. (TSX.V: EVGN) (OTCQX: EVGIF) Leads the Way Towards a Renewable Energy-Powered Future Within Canada

Posted on November 29, 2022 by MissionIR

The United Nations Framework Convention on Climate Change – better known as COP27 – is taking place in Egypt’s Sharm el-Sheikh amidst one of the most significant climate emergencies ever experienced by man. A growing energy crisis, record greenhouse gas … Continue reading →

Posted in EverGen Infrastructure Corp. EVGIF | Leave a comment

MissionIRNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) 1-for-30 Reverse Stock Split Now in Place

Posted on November 29, 2022 by MissionIR

CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, has announced a 1-for-30 reverse split of its common stock. According to the announcement, … Continue reading →

Posted in CNS Pharmaceuticals Inc. CNSP | Leave a comment

Lexaria Bioscience Corp. (NASDAQ: LEXX) Expands Investigation of DehydraTECH-CBD’s Potential Therapeutic Value for Diabetes and Defmentia with New Studies

Posted on November 29, 2022 by MissionIR

Lexaria Bioscience (NASDAQ: LEXX) just announced two notable studies, DEM-A22-1, and DIAB-A22-1, on dementia and diabetes, respectively, scheduled for completion in January 2023. The studies seek a deeper understanding of the company’s patented DehydraTECH(TM)-processed CBD for its potential therapeutic utility … Continue reading →

Posted in Lexaria Bioscience Corp. LEXX | Leave a comment

MissionIRNewsBreaks – Aditxt Inc. (NASDAQ: ADTX) Featured in Equity Research Reports

Posted on November 28, 2022 by MissionIR

Aditxt (NASDAQ: ADTX), a biotech innovation company developing and commercializing technologies with a focus on monitoring and modulating the immune system, was featured in recent equity research reports published by H.C. Wainwright & Co. Titled “Personalizing Precision Immunological Therapy; Initiating … Continue reading →

Posted in Aditxt Inc. ADTX | Leave a comment

Correlate Infrastructure Partners Inc. (CIPI) Helps Clients Achieve ESG Goals Through Proprietary Analytics, Advisement

Posted on November 28, 2022 by MissionIR

Environmental, social and governance (“ESG”) responsibility has come to define corporate attention to climate change and steady drive toward clean energy adoption. While nearly a decade has passed since some 200 international entities and their governments forged a compact for … Continue reading →

Posted in Correlate Infrastructure Partners Inc. CIPI | Leave a comment

MissionIRNewsBreaks – Knightscope, Inc. (NASDAQ: KSCP) K1 Technology Deployed for Transit System Client

Posted on November 28, 2022 by MissionIR

Knightscope (NASDAQ: KSCP), a leading developer of autonomous security robots, has announced that an existing California-based transit client signed a contract to upgrade 97 of its parking lot emergency call boxes with the Knightscope K1 Retrofit Kits. The announcement reads, … Continue reading →

Posted in Knightscope Inc. KSCP | Leave a comment

MissionIRNewsBreaks – FingerMotion Inc. (NASDAQ: FNGR) to Participate in Upcoming One-on-One Investor Conference

Posted on November 28, 2022 by MissionIR

FingerMotion (NASDAQ: FNGR) CEO Martin Shen is scheduled to participate in one-on-one meetings during the Benchmark Company’s 11th annual Discovery One-on-One Investor Conference. The one-day event is scheduled for Dec. 1, 2022, in New York City. During the conference, Shen … Continue reading →

Posted in FingerMotion Inc. FNGR | Leave a comment

MissionIRNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC) Announces Q3 2022 Financial Results

Posted on November 28, 2022 by MissionIR

Flora (NASDAQ: FLGC), a leading all-outdoor cultivator, manufacturer and distributor of global cannabis products and brands, released its financial and operating results for the third quarter and nine months ended Sept. 30, 2022. Among the highlights, the company reported 414% … Continue reading →

Posted in Flora Growth Corp. FLGC | Leave a comment